Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathurin Fumery

Showing results (181-190 of 254) with videos related to

Pageof 26
Sort By:
Gut|February 23, 2019
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrenceMatthieu Allez, Claire Auzolle, Marjolaine Ngollo, et al.
Journal of Crohn'S & Colitis|August 25, 2025
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label studyXavier Roblin, Sophie Vieujean, Stéphane Nancey, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.
Cancers|April 13, 2023
Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn's Disease: A Multicentre Case-Control StudyCapucine Chappe, Cecile Salut, Aurelien Amiot, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAIDMathieu Uzzan, Maria Nachury, Alexandre Nuzzo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative ProctitisGuillaume Pineton de Chambrun, Aurélien Amiot, Guillaume Bouguen, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort StudyNicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter StudyMathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, et al.
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Pageof 26

Showing results (181-190 of 254) with videos related to

Sort By:
Pageof 26
Gut|February 23, 2019
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrenceMatthieu Allez, Claire Auzolle, Marjolaine Ngollo, et al.
Journal of Crohn'S & Colitis|August 25, 2025
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label studyXavier Roblin, Sophie Vieujean, Stéphane Nancey, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.
Cancers|April 13, 2023
Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn's Disease: A Multicentre Case-Control StudyCapucine Chappe, Cecile Salut, Aurelien Amiot, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAIDMathieu Uzzan, Maria Nachury, Alexandre Nuzzo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative ProctitisGuillaume Pineton de Chambrun, Aurélien Amiot, Guillaume Bouguen, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort StudyNicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Journal of Crohn'S & Colitis|September 8, 2020
Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter StudyMathurin Fumery, Laurent Peyrin-Biroulet, Stephane Nancey, et al.
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Pageof 26